PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Precision System Science Co., Ltd.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (12)

Precision System Science Co., Ltd. owes ¥0.30 for every ¥1 it owns.

Compared with Healthcare companies in Japan · latest annual results Jun 2026.

P/E ratio

14.4

Investors pay ¥14.4 for every ¥1 of Precision System Science Co., Ltd.'s yearly profit, lower than 58% of Healthcare companies in Japan.

P/B ratio

1.39

The share price is 1.39 times Precision System Science Co., Ltd.'s book value per share, lower than 58% of Healthcare companies in Japan.

Market cap

¥5.7 B

The total market value of all of Precision System Science Co., Ltd.'s shares at today's price (share price × number of shares), smaller than 78% of Healthcare companies in Japan. PosiCap size class: Micro Cap.

Net worth (book value)

¥4.1 B

What Precision System Science Co., Ltd. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

¥148.94

Net worth divided by the number of shares. The share price of ¥207.00 is 1.4 times this, which is the P/B above.

Return on equity (ROE)

10.0%

Precision System Science Co., Ltd. earned 10.0% on its shareholders' money over the last year, higher than 65% of Healthcare companies in Japan.

Owes vs Owns

0.30×

Precision System Science Co., Ltd. owes ¥0.30 for every ¥1 it owns (low), lower than 58% of Healthcare companies in Japan.

Dividend yield

2.90%

Precision System Science Co., Ltd. pays 2.90% of its share price as dividends a year, higher than 53% of dividend-paying Healthcare companies in Japan.

Profit margin

7.6%

Precision System Science Co., Ltd. keeps ¥8 of every ¥100 of revenue as net profit.

Cash quality

0.1×

Cash from Precision System Science Co., Ltd.'s business was 0.1× its reported profit in the year to Jun 2026 — less cash came in than the profit reported.

Interest cover

12.0×

Precision System Science Co., Ltd.'s operating profit covered its interest costs 12.0 times in the year to Jun 2026.

Cash vs debt

Net cash

Precision System Science Co., Ltd. held ¥341 M more cash than debt (net cash) at Jun 2026.

Questions

What is Precision System Science Co., Ltd.'s P/E ratio?

Investors pay ¥14.4 for every ¥1 of Precision System Science Co., Ltd.'s yearly profit, lower than 58% of Healthcare companies in Japan.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Precision System Science Co., Ltd.: ¥5.7 B ÷ ¥4.1 B (30 Jun 2026) = 1.4.

What is Precision System Science Co., Ltd.'s return on equity?

Precision System Science Co., Ltd. earned 10.0% on its shareholders' money over the last year, higher than 65% of Healthcare companies in Japan.

How much does Precision System Science Co., Ltd. owe compared with what it owns?

Precision System Science Co., Ltd. owes ¥0.30 for every ¥1 it owns (low), lower than 58% of Healthcare companies in Japan.

Does Precision System Science Co., Ltd. pay a dividend?

Yes. Precision System Science Co., Ltd. pays 2.90% of its share price as dividends a year, higher than 53% of dividend-paying Healthcare companies in Japan.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.